Stephane Culine
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 293 publications
Phase Ib Trial of Bavdegalutamide (ARV-110) in Combination with Abiraterone for Metastatic Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 27, 2026
Squamous cell carcinoma of the bladder: Current evidence, therapeutic challenges, and research perspectives from the French AVENTUR group.
Journal: Critical reviews in oncology/hematology
Published: January 17, 2026
Squamous cell carcinoma of the bladder: Current evidence, therapeutic challenges, and research perspectives from the French AVENTUR group.
Journal: Critical reviews in oncology/hematology
Published: January 17, 2026
Survival modelling of relapse-free survival and competing-risk analysis in patients with high-risk localized prostate cancer treated in GETUG-12.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 07, 2026
Cooperation between hematologists and geriatricians
Journal: Soins. Gerontologie
Published: November 13, 2025
Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 13, 2025
Does perioperative chemotherapy affect renal function after radical nephroureterectomy for upper tract urothelial carcinoma?
Journal: World journal of urology
Published: October 13, 2025
Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating Adjuvant Leuprorelin Acetate After Radical Prostatectomy in Men with High-risk Localized Prostate Cancer.
Journal: European urology oncology
Published: October 09, 2025
Perspectives of positron emission tomography with 2-deoxy-2-fluorine-18-flu-d-glucose (18fdg-pet) in predicting the histological response of high grade epithelial ovarian cancer to neoadjuvant chemotherapy. A primary descriptive study.
Journal: American journal of nuclear medicine and molecular imaging
Published: September 12, 2025
Prognostic Factors for Overall Survival in the VESPER Trial: Basal Molecular Subtype Is a Relevant Key Factor.
Journal: European urology oncology
Published: September 02, 2025
Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study).
Journal: Lung Cancer (Auckland, N.Z.)
Published: April 22, 2025
Epidemiology, resource use, and treatment patterns of locally advanced or metastatic urothelial carcinoma in France.
Journal: Future oncology (London, England)
Published: February 20, 2025
Last Updated: 09/26/2026